The Glioma International Case-Control Study: A Report from the Genetic Epidemiology of Glioma International Consortium

American Journal of Epidemiology

Volumn 183, Issue 2, 2016, Pages 85-91

  Amirian, E Susan ^a   Armstrong, Georgina N ^a   Zhou, Renke ^a   Lau, Ching C ^a   Claus, Elizabeth B ^b,c   Barnholtz Sloan, Jill S ^d   Il'Yasova, Dora ^e,f   Schildkraut, Joellen ^f   Ali Osman, Francis ^f   Sadetzki, Siegal ^g,h   Johansen, Christoffer ^i,j   Houlston, Richard S ^k   Jenkins, Robert B ^l   Lachance, Daniel ^l   Olson, Sara H ^m   Bernstein, Jonine L ^m   Merrell, Ryan T ⁿ   Wrensch, Margaret R ^o   Davis, Faith G ^p   Lai, Rose ^q   Shete, Sanjay ^r   Amos, Christopher I ^s   Scheurer, Michael E ^a   Aldape, Kenneth ^t   Alafuzoff, Irina ^u   Brännström, Thomas ^v   Broholm, Helle ^j   Collins, Peter ^w   Giannini, Caterina ^k   Rosenblum, Marc ^m   Tihan, Tarik ^o   Melin, Beatrice S ^v   Bondy, Melissa L ^a   more..

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e GEORGIA STATE UNIVERSITY   (United States)

^f DUKE UNIVERSITY MEDICAL CENTER   (United States)

^g GERTNER INSTITUTE FOR EPIDEMIOLOGY AND HEALTH POLICY RESEARCH   (Israel)

^h TEL AVIV UNIVERSITY   (Israel)

ⁱ INSTITUTE OF CANCER EPIDEMIOLOGY   (Denmark)

^j UNIVERSITY OF COPENHAGEN   (Denmark)

^k INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^l MAYO CLINIC CANCER CENTER   (United States)

^m MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

ⁿ NORTHSHORE UNIVERSITY HEALTHSYSTEM   (United States)

^o UNIVERSITY OF CALIFORNIA   (United States)

^p UNIVERSITY OF ALBERTA   (Canada)

^q UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^r UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^s DARTMOUTH MEDICAL SCHOOL   (United States)

^t UNIVERSITY OF TORONTO   (Canada)

^u UPPSALA UNIVERSITY   (Sweden)

^v UMEÅ UNIVERSITY   (Sweden)

^w UNIVERSITY OF CAMBRIDGE   (United Kingdom)

more..

Author keywords

cancer; case control studies; glioblastoma; glioma; methodology; study profile

Indexed keywords

BLOOD; CANCER; EPIDEMIOLOGY; ETIOLOGY; GENETIC ANALYSIS; HETEROGENEITY; RESEARCH WORK; STUDY METHOD; TUMOR;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CASE CONTROL STUDY; CLINICAL ARTICLE; CONTROLLED STUDY; ENVIRONMENTAL EXPOSURE; FEMALE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC EPIDEMIOLOGY; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE ENVIRONMENT INTERACTION; GLIOMA; HUMAN; MALE; MIDDLE AGED; QUESTIONNAIRE; ADOLESCENT; BLOOD; GENETIC PREDISPOSITION; GENETICS; INCIDENCE; INTERNATIONAL COOPERATION; MOLECULAR EPIDEMIOLOGY; PROCEDURES; RETROSPECTIVE STUDY; RISK FACTOR; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; FEMALE; GENE-ENVIRONMENT INTERACTION; GENETIC PREDISPOSITION TO DISEASE; GLIOMA; HUMANS; INCIDENCE; INTERNATIONAL COOPERATION; MALE; MIDDLE AGED; MOLECULAR EPIDEMIOLOGY; RETROSPECTIVE STUDIES; RISK FACTORS; YOUNG ADULT;

EID: 84960080630     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kwv235     Document Type: Article

References (31)

1. Adamson C, Kanu OO, Mehta AI, et al. Glioblastoma multiforme: a review of where we have been and where we are going. Expert Opin Investig Drugs. 2009;18(8): 1061-1083.
2. Ohgaki H, Kleihues P. Epidemiology and etiology of gliomas. Acta Neuropathol. 2005;109(1):93-108.
3. Ferlay J, Shin H, Bray F. GLOBOCAN 2008: Cancer Incidence and Mortality Worldwide in 2008. Lyon, France: International Agency for Research on Cancer; 2008.
4. Ostrom QT, Gittleman H, Liao P, et al. CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2007-2011. Neuro Oncol. 2014;16(suppl 4):iv1-iv63.
5. Rajaraman P, Melin BS, Wang Z, et al. Genome-wide association study of glioma and meta-analysis. Hum Genet. 2012;131(12):1877-1888.
6. Ostrom QT, Gittleman H, Stetson L, et al. Epidemiology of gliomas. Cancer Treat Res. 2015;163:1-14.
7. Shete S, Hosking FJ, Robertson LB, et al. Genome-wide association study identifies five susceptibility loci for glioma. Nat Genet. 2009;41(8):899-904.
8. Wrensch M, Jenkins RB, Chang JS, et al. Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibility. Nat Genet. 2009;41(8): 905-908.
9. Chen H, Chen Y, Zhao Y, et al. Association of sequence variants on chromosomes 20, 11, and 5 (20q13.33, 11q23.3, and 5p15.33) with glioma susceptibility in a Chinese population. Am J Epidemiol. 2011;173(8):915-922.
10. Ostrom QT, Bauchet L, Davis FG, et al. The epidemiology of glioma in adults: a "state of the science" review. Neuro Oncol. 2014;16(7):896-913.
11. Egan KM, Thompson RC, Nabors LB, et al. Cancer susceptibility variants and the risk of adult glioma in a US case-control study. J Neurooncol. 2011;104(2):535-542.
12. Malmer B, Adatto P, Armstrong G, et al. GLIOGENE-an international consortium to understand familial glioma. Cancer Epidemiol Biomarkers Prev. 2007;16(9):1730-1734.
13. Jalali A, Amirian ES, Bainbridge MN, et al. Targeted sequencing in chromosome 17q linkage region identifies familial glioma candidates in the Gliogene Consortium. Sci Rep. 2015;5:8278.
14. Bainbridge MN, Armstrong GN, Gramatges MM, et al. Germline mutations in shelterin complex genes are associated with familial glioma. J Natl Cancer Inst. 2015;107(1):dju384.
15. Rothman KJ, Greenland S, Lash TL. Modern Epidemiology. 3rd ed. Philadelphia, PA: LippincottWilliams&Wilkins; 2008.
16. Wacholder S, Silverman DT, McLaughlin JK, et al. Selection of controls in case-control studies. II. Types of controls. Am J Epidemiol. 1992;135(9):1029-1041.
17. Breslow NE, Day NE. Statistical methods in cancer research. Volume I-the analysis of case-control studies. IARC Sci Publ. 1980;32:5-338.
18. Mendonça GA, Eluf-Neto J. Hospital visitors as controls in case-control studies. Rev Saude Publica. 2001;35(5):436-442.
19. Armenian HK, Lakkis NG, Sibai AM, et al. Hospital visitors as controls. Am J Epidemiol. 1988;127(2):404-406.
20. Li L, Zhang M, Holman D. Population versus hospital controls for case-control studies on cancers in Chinese hospitals. BMC Med Res Methodol. 2011;11:167.
21. Gupta T, Nair V, Epari S, et al. Concordance between local, institutional, and central pathology review in glioblastoma: implications for research and practice: a pilot study. Neurol India. 2012;60(1):61-65.
22. Gilles FH, Tavaré CJ, Becker LE, et al. Pathologist interobserver variability of histologic features in childhood brain tumors: results from the CCG-945 study. Pediatr Dev Pathol. 2008;11(2):108-117.
23. Bruner JM, Inouye L, Fuller GN, et al. Diagnostic discrepancies and their clinical impact in a neuropathology referral practice. Cancer. 1997;79(4):796-803.
24. Scott CB, Nelson JS, Farnan NC, et al. Central pathology review in clinical trials for patients with malignant glioma. A report of Radiation Therapy Oncology Group 83-02. Cancer. 1995;76(2):307-313.
25. Louis DN, Ohgaki H, Wiestler OD, et al., eds. WHO Classification of Tumours of the Central Nervous System. 4th ed. Lyon, France: IARC Press; 2007.
26. Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5): 373-383.
27. Hedges L, Vevea J. Fixed- and random-effects models in meta-analysis. Psychol Methods. 1998;3(4):486-504.
28. Debray TP, Moons KG, Abo-Zaid GM, et al. Individual participant data meta-analysis for a binary outcome: one-stage or two-stage? PLoS One. 2013;8(4):e60650.
29. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21(11):1539-1558.
30. Lewis S, Clarke M. Forest plots: trying to see the wood and the trees. BMJ. 2001;322(7300):1479-1480.
31. INTERPHONE Study Group. Brain tumour risk in relation to mobile telephone use: results of the INTERPHONE international case-control study. Int J Epidemiol. 2010;39(3): 675-694.